129 related articles for article (PubMed ID: 31117848)
1. Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines.
Kazemi Sefat NA; Mohammadi MM; Hadjati J; Talebi S; Ajami M; Daneshvar H
Immunol Invest; 2019 Oct; 48(7):759-769. PubMed ID: 31117848
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells.
Ozkan AD; Eskiler GG; Kazan N; Turna O
J Cancer Res Ther; 2023 Oct; 19(7):1812-1817. PubMed ID: 38376283
[TBL] [Abstract][Full Text] [Related]
3. Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.
Han A; Bennett N; MacDonald A; Johnstone M; Whelan J; Donohoe DR
J Cell Physiol; 2016 Aug; 231(8):1804-13. PubMed ID: 26661480
[TBL] [Abstract][Full Text] [Related]
4. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.
Shin J; Carr A; Corner GA; Tögel L; Dávalos-Salas M; Tran H; Chueh AC; Al-Obaidi S; Chionh F; Ahmed N; Buchanan DD; Young JP; Malo MS; Hodin RA; Arango D; Sieber OM; Augenlicht LH; Dhillon AS; Weber TK; Mariadason JM
J Biol Chem; 2014 Sep; 289(36):25306-16. PubMed ID: 25037223
[TBL] [Abstract][Full Text] [Related]
5. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells.
Silva LG; Ferguson BS; Avila AS; Faciola AP
J Anim Sci; 2018 Dec; 96(12):5244-5252. PubMed ID: 30252114
[TBL] [Abstract][Full Text] [Related]
6. Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.
Yamamura T; Matsumoto N; Matsue Y; Okudera M; Nishikawa Y; Abiko Y; Komiyama K
Anticancer Res; 2014 Apr; 34(4):1701-8. PubMed ID: 24692699
[TBL] [Abstract][Full Text] [Related]
7. Sodium Butyrate Inhibits the Inflammation of Lipopolysaccharide-Induced Acute Lung Injury in Mice by Regulating the Toll-Like Receptor 4/Nuclear Factor κB Signaling Pathway.
Liu J; Chang G; Huang J; Wang Y; Ma N; Roy AC; Shen X
J Agric Food Chem; 2019 Feb; 67(6):1674-1682. PubMed ID: 30661349
[TBL] [Abstract][Full Text] [Related]
8. The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia.
Jaworska J; Ziemka-Nalecz M; Sypecka J; Zalewska T
J Neuroinflammation; 2017 Feb; 14(1):34. PubMed ID: 28187734
[TBL] [Abstract][Full Text] [Related]
9. The impact of the histone deacetylase inhibitor sodium butyrate on microglial polarization after oxygen and glucose deprivation.
Ziabska K; Gargas J; Sypecka J; Ziemka-Nalecz M
Pharmacol Rep; 2022 Oct; 74(5):909-919. PubMed ID: 35796871
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells.
Li L; Sun Y; Liu J; Wu X; Chen L; Ma L; Wu P
BMC Biochem; 2015 Jan; 16():2. PubMed ID: 25592494
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
[TBL] [Abstract][Full Text] [Related]
12. Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models.
Zapletal O; Tylichová Z; Neča J; Kohoutek J; Machala M; Milcová A; Pokorná M; Topinka J; Moyer MP; Hofmanová J; Kozubík A; Vondráček J
Arch Toxicol; 2017 May; 91(5):2135-2150. PubMed ID: 27830268
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate improves porcine host defense peptide expression and relieves the inflammatory response upon Toll-like receptor 2 activation and histone deacetylase inhibition in porcine kidney cells.
Dou X; Han J; Song W; Dong N; Xu X; Zhang W; Shan A
Oncotarget; 2017 Apr; 8(16):26532-26551. PubMed ID: 28460447
[TBL] [Abstract][Full Text] [Related]
14. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
[TBL] [Abstract][Full Text] [Related]
15. Low-Intensity Ultrasound Enhances Histone Acetylation and Inhibition of Interleukin 6 Messenger RNA Expression by the Histone Deacetylase Inhibitor Sodium Butyrate in Fibroblasts.
Maeshige N; Koga Y; Tanaka M; Aoyama-Ishikawa M; Miyoshi M; Usami M; Fujino H
J Ultrasound Med; 2017 May; 36(5):879-885. PubMed ID: 28195362
[TBL] [Abstract][Full Text] [Related]
16. Different effect of sodium butyrate on cancer and normal prostate cells.
Paskova L; Smesny Trtkova K; Fialova B; Benedikova A; Langova K; Kolar Z
Toxicol In Vitro; 2013 Aug; 27(5):1489-95. PubMed ID: 23524101
[TBL] [Abstract][Full Text] [Related]
17. TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression.
Ye K; Wu Y; Sun Y; Lin J; Xu J
Life Sci; 2016 Jun; 155():133-9. PubMed ID: 27177773
[TBL] [Abstract][Full Text] [Related]
18. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Weaver EM; Zamora FJ; Puplampu-Dove YA; Kiessu E; Hearne JL; Martin-Caraballo M
Eur J Pharmacol; 2015 Feb; 749():20-31. PubMed ID: 25557765
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation.
Hu QP; Mao DA
BMC Neurosci; 2016 May; 17(1):22. PubMed ID: 27193049
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated process.
Rahmani M; Dai Y; Grant S
Exp Cell Res; 2002 Jul; 277(1):31-47. PubMed ID: 12061815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
